Furthermore, the renal failure marker cystatine C should be monitored in patients older than 20 years of age with DMD; the association between cardiac and renal dysfunction in patients with advanced-stage DMD was described [11]. This evidence concerns the gene CST3 and Duchenne muscular dystrophy.